NextPlat (NXPL) Treasury Shares (2025 - 2026)

NextPlat's (NXPL) quarterly Treasury Shares came in at $100000.0 in Q2 2026, little changed quarter-over-quarter from $100000.0 in Q1 2026.

Analysis

NextPlat (NXPL) Treasury Shares (2025 - 2026) Analysis & Trends

NextPlat (NXPL) has reported Treasury Shares for 2 consecutive years, with $100000.0 the latest figure, recorded in Q2 2026.

On a quarterly basis, Treasury Shares changed N/A year-over-year to $100000.0 in Q2 2026; TTM through Jun 2026 was $100000.0, a N/A change from a year earlier, with the FY2025 full-year figure at $100000.0, changed N/A from the prior year.
Treasury Shares was $100000.0 for Q2 2026 at NextPlat, roughly flat from $100000.0 in the prior quarter.
Over five years, Treasury Shares peaked at $130549.0 in Q3 2025 and troughed at $13054.0 in Q4 2025.

Peer Set

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Treasury Shares (Qtr)
1	Teva Pharmaceutical Industries	42.34 Bn	38.68 Bn	2.15 Bn	106.00 Mn
2	Viatris	19.39 Bn	18.50 Bn	1.46 Bn	1.16 Bn
3	Dr Reddys Laboratories	9.99 Bn	9.85 Bn	396.53 Mn	-16.50 Mn
4	Amneal Pharmaceuticals	5.57 Bn	5.53 Bn	334.51 Mn	-
5	Bausch Health Companies	2.45 Bn	1.58 Bn	2.10 Bn	-
6	Ani Pharmaceuticals	1.70 Bn	1.34 Bn	165.89 Mn	53.82 Mn
7	Alvotech	1.66 Bn	1.52 Bn	2.56 Mn	-
8	Amphastar Pharmaceuticals	985.90 Mn	695.77 Mn	93.47 Mn	-19.77 Mn
9	Fennec Pharmaceuticals	434.07 Mn	392.82 Mn	17.15 Mn	-
10	NextPlat	24.77 Mn	12.93 Mn	4.69 Mn	13,054.00

Historic Data

Download Data